Skin-like chitosan-based gel dressing capable of being trained and strengthened

By modifying the combination of chitosan macromolecules, hydrogen-bonding macromolecules and zwitterionic macromolecules, a training-based chitosan gel material was prepared, solving the mechanical properties and drug loading of existing dressings. The problem of insufficient drug capacity has achieved efficient loading and sustained release biopharmaceuticals, meeting the needs of the field of regenerative medicine, and significantly improving its strength in stretching.

CN118903532APending Publication Date: 2024-11-08HUNAN UNIV OF TECH

Patent Information

Application Number
CN202410835055.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-26
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The existing chitosan-based dressings have shortcomings in mechanical properties, drug loading capacity and sustained release capacity, and are particularly difficult to meet the needs of the regenerative medicine field for conductivity, breathability and special drug loads.

Method used

By modifying the combination of chitosan macromolecules, hydrogen-bonding macromolecules and zwitterionic macromolecules, the mechanical properties and conductivity of the gel are regulated, and a training-based shell polypropylene is prepared by combining aldehyde-based crosslinking agents. Glycosyl gel material that achieves drug loading and sustained release and strengthens its strength during tensile.

Benefits of technology

The gel material has good mechanical properties, antibacterial properties and conductivity, and can payload and sustained release of biological drugs, especially stem cells and stem cell exosomes, improves the therapeutic effect of the dressing and significantly improves the stretching process. Its strength.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118903532A_ABST
    Figure CN118903532A_ABST
Patent Text Reader

Abstract

The invention relates to a skin-like chitosan-based gel dressing capable of being trained and strengthened. The gel is composed of polypeptide modified chitosan macromolecules, cation modified chitosan, macromolecules capable of achieving hydrogen-bond interaction and zwitterionic macromolecules. The gel has good mechanical properties, and has a certain strength improvement effect in the repeated pulling deformation process. Meanwhile, the gel also has electrical conductivity, good biocompatibility, antibacterial property and special drug loading and slow-release capability, has the characteristics similar to that of human skin, and can be applied to the field of biological medicines such as wound dressing and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a gel material, and in particular to a chitosan-based gel material which has good mechanical properties, electrical conductivity, and antibacterial properties, can improve strength through stretching training, and can achieve drug loading and sustained release. Background Art

[0002] Open wounds on the human body are prone to infection, especially those caused by certain special diseases such as diabetes, which are difficult to heal. How to effectively reduce the probability of wound infection and promote wound recovery and tissue refunctionalization is a hot topic and difficulty that needs to be solved in the medical community. Dressings, as a covering treatment method, can effectively protect wounds and provide therapeutic drugs, and are the main wound treatment method. Traditional dressings such as gauze and bandages are made of dry fabrics, which have limited absorption of exudate and are easy to damage newly generated tissues when removed, causing secondary damage. Hydrogels are a good choice for wound dressings due to their own swelling, water retention and easy removal properties. Chitosan itself has good antibacterial and cell compatibility and is often used in the fields of medicine and biology. However, the current gel dressings still have the characteristics of mechanical properties not being suitable, insufficient drug loading capacity and sustained release capacity, especially when ordinary drugs are difficult to act on special wounds, regenerative medicine methods such as stem cells and exosomes will greatly improve the treatment effect. However, how to find a suitable carrier to achieve effective loading and controllable sustained release is still a major problem.

[0003] Chitosan itself has good antibacterial and cell compatibility, and is often used in the fields of medicine and biology. Chitosan is a natural alkaline polysaccharide, and its chemical name is β-(1,4)-2-amino-2-deoxy-D-glucose. Chitosan is an amino sugar molecule with a strong positive charge, which has a strong attraction to negatively charged molecules. Therefore, through electrostatic action, it can produce electrostatic adsorption with negatively charged bacterial cell walls, thereby destroying the bacterial cell walls. Chitosan has very excellent biological properties and material processability. In recent years, porous scaffolds, microspheres, hydrogels, etc. prepared from chitosan materials have been widely used as drug carriers, cell scaffolds, wound dressings, surgical sutures, etc. In recent years, a variety of chitosan-based gels have been widely developed, achieving good antibacterial and mechanical properties. However, as a dressing material, especially in the field of regenerative medicine, there are still some defects. First, the ideal dressing material should have similar properties to the skin to ensure better comfort; second, it needs to provide more functionality such as conductivity and breathability to meet the needs of personalized treatment; third, it can better load special drugs such as stem cells and stem cell exosomes to meet the needs of regenerative medicine treatment. The current chitosan-based dressings still cannot fully meet the requirements.

[0004] In response to the above problems, the present invention provides a novel method for constructing chitosan-based dressing materials. Good loading and sustained release of biological drugs are achieved through polypeptide modification of chitosan itself, and the interaction regulation of hydrogen-bonding macromolecules and zwitterionic macromolecules is combined to achieve good mechanical properties and enhanced strength during stretching. The introduction of conductivity is combined to achieve a gel-like skin effect, which is expected to achieve better dressing treatment effects. Summary of the invention

[0005] The present invention is dedicated to overcoming at least one of the current technical difficulties and providing a gel material with good mechanical properties and antibacterial properties, and in particular, providing a chitosan-based gel material that can load biological drugs and can further improve mechanical properties through training.

[0006] The objective of the present invention is achieved through the following technical solutions: A trainable and strengthening skin chitosan-based gel dressing, which is composed of polypeptide-modified chitosan macromolecules, hydrogen-bonding macromolecules, and zwitterionic macromolecules, and the mass fraction of each component is: Peptide modified chitosan macromolecule: 4-8 Cationic modified chitosan: 15-40 Hydrogen bondable macromolecules: 5-12 Zwitterionic macromolecules: 10-30 Aldehyde crosslinking agent: 0.1-0.5 Furthermore, the polypeptide is a cyclic peptide or a water-soluble cyclic peptide derivative, and its content in the polypeptide-modified chitosan macromolecule is between 10-40% of the mass of chitosan.

[0007] Furthermore, the cyclic peptide is a five-membered cyclic peptide, which is composed of arginine, glycine, aspartic acid, D-phenylalanine, and lysine, and the first and last amide bonds form a ring, and its molecular structure is as follows:

[0008] Furthermore, the cyclopeptide-modified chitosan-based macromolecule can be directly purchased from the market, or chitosan can be modified in solution by electrostatic adsorption, condensed by the amino group of the chitosan macromolecule, accessed by Schiff base reaction, or synthesized by the method described in 201811542507.4 after improvement according to actual proportions and needs, as follows: Dissolve aminopolyethylene glycol 2000 in a small amount of anhydrous dimethyl sulfoxide. According to the molar ratio of aminopolyethylene glycol 2000: disuccinimide being between 1:1.5 and 1:2.5, take disuccinimide and dissolve it in an appropriate amount of anhydrous dimethyl sulfoxide. Slowly drop the dimethyl sulfoxide solution of disuccinimide into the dimethyl sulfoxide solution of polyethylene glycol 2000, and stir at room temperature for 2 to 9 hours to obtain reaction solution 1. According to the molar ratio of polyethylene glycol 2000: cyclopeptide being between 1:0.5 and 1:1.5, take the cyclopeptide and dissolve it in an appropriate amount of anhydrous dimethyl sulfoxide. Sulfoxide, prepare a solution with a concentration of 5.0 mg / mL, slowly add the anhydrous dimethyl sulfoxide solution of the cyclopeptide to the reaction solution 1, stir at room temperature for 1 to 12 hours to obtain the reaction solution 2, take chitosan according to the molar ratio of free amino groups on chitosan: cyclopeptide of 3:1 to 20:1, slowly add the reaction solution 2 to the weak acid aqueous solution of chitosan, stir at room temperature for 1 to 24 hours, place the final reaction solution in a dialysis bag with a molecular weight cutoff of 4000, dialyze with distilled water for 48 hours, and freeze-dry to obtain the cyclopeptide-chitosan modified product.

[0009] Furthermore, the water-soluble cyclic peptide derivative may be one of cyclic peptide-polyethylene glycol-folic acid and cyclic peptide-polyethylene glycol-amino, and may be purchased from the market or modified by oneself.

[0010] Furthermore, the cationic modified chitosan is quaternary ammonium salt modified chitosan; preferably, it is hydroxypropyltrimethylammonium chloride chitosan, and its modification substitution degree is between 15-30% calculated by the mass of chitosan.

[0011] Furthermore, it includes one of polyacrylamide and its hydrophilic derivatives, poly(N-hydroxyethyl acrylamide), and polyethylene glycol-polyvinyl alcohol graft copolymer.

[0012] Furthermore, the hydrophilic derivatives of polyacrylamide include poly-N,N'-dimethylacrylamide, poly-N,N'-diethylacrylamide and the like.

[0013] Furthermore, the mass of polyvinyl alcohol in the polyethylene glycol-polyvinyl alcohol graft copolymer is between 30-60% of the polyethylene glycol.

[0014] Furthermore, the zwitterionic macromolecule is one of polymethacrylate sulfobetaine, polymethacryloylethyl sulfobetaine, polymethacrylate carboxybetaine, polymethyl acrylate cysteine, and polymethyl acrylate serine, and its molecular weight is between 30,000 and 60,000.

[0015] Further, preferably, the zwitterionic macromolecule is poly([2-(methacryloyloxy)ethyl]dimethyl-(3-sulfonic acid propyl)ammonium hydroxide).

[0016] Furthermore, the molecular structures of the polymethyl acrylate cysteine ​​and polymethyl acrylate serine are as follows: Polymethyl acrylate cysteine:

[0017] Polymethylacrylate Serine:

[0018] Furthermore, the aldehyde-based crosslinking agent can be a small molecule aldehyde-based crosslinking agent and a macromolecular aldehyde-based crosslinking agent; the small molecule aldehyde-based crosslinking agent is glutaraldehyde, and the macromolecular aldehyde-based crosslinking agent is terminal aldehyde multi-arm polyethylene glycol, with a molecular weight between 2000-6000.

[0019] Furthermore, the aldehyde-terminated multi-arm polyethylene glycol is one of 4-arm aldehyde-terminated polyethylene glycol, 6-arm aldehyde-terminated polyethylene glycol, and 8-arm aldehyde-terminated polyethylene glycol.

[0020] For example, the molecular structure of 4-arm terminal aldehyde polyethylene glycol is as follows:

[0021] Further, the preparation process of the gel is: I: dissolving the cationic modified chitosan in a weak acid aqueous solution with a pH value between 5 and 6.5, with a mass concentration between 3 and 8%; adding the polypeptide modified chitosan macromolecule after stirring evenly, and continuing to stir evenly to form a prepolymer solution A; II: dissolving the hydrogen-bonding macromolecule, the zwitterionic macromolecule, and the aldehyde-based crosslinking agent in deionized water, and stirring them evenly to obtain a prepolymer solution B, wherein the mass concentration of the solute is between 10-20%; III: Add prepolymer solution B to prepolymer solution A, stir evenly, then add a small amount of NaOH aqueous solution to adjust the pH value of the solution to between 9-10.5; IV: Heat the mixed solution to 35-45 o C, keep for 4-8 hours to obtain gel; V: The gel is repeatedly soaked and washed with pure water, and the pH value is adjusted to between 7 and 8 to obtain the final product.

[0022] Furthermore, during the preparation process of the polypeptide-modified chitosan, as the pH value is adjusted close to the isoelectric point (pK≈10) of the polypeptide, the ionic bonding between the polypeptide and itself and the ionic modified chitosan is promoted to achieve the strengthening of the gel network structure.

[0023] Furthermore, the gel can effectively load stem cells, stem cell exosomes and other drugs and achieve sustained release, and the loading process can add the required loaded drugs in process II. This good loading effect is due to the good biocompatibility of chitosan itself and the good binding and compatibility of polypeptide groups and ionic groups with stem cells and exosomes with polar surfaces.

[0024] Furthermore, the stem cell exosomes may be mesenchymal stem cell exosomes, adipose-derived stem cell exosomes, pluripotent stem cell exosomes, etc. Calculated based on the proportion of each material in the present invention, the concentration of stably loaded exosomes can reach 20-50 mg / g gel.

[0025] Furthermore, the stem cells can be any one of adipose mesenchymal stem cells, umbilical cord mesenchymal stem cells, and bone marrow mesenchymal stem cells, and their stable loading content in the gel can reach 4*10 4 -5*10 5 Pieces / mL.

[0026] Furthermore, the gel can also be loaded with other types of water-soluble drugs, such as doxorubicin hydrochloride, levofloxacin hydrochloride, etc.

[0027] Furthermore, the gel can achieve strength enhancement during repeated stretching-relaxation within the tensile fracture deformation range, with the enhancement limit being between 50% and 100% of the initial tensile strength. This strengthening effect should be attributed to the rearrangement of interaction groups such as multiple ion interaction groups during the stretching process of the molecular chain.

[0028] Furthermore, the cyclic peptide has cell adhesion and can bind to integrin receptors on the surfaces of various cells, especially αvβ3 and αvβ5 integrins, which is beneficial to the release of the gel dressing itself and the bound drugs on the skin surface and angiogenic cells.

[0029] Furthermore, due to the presence of ionic polymers and hydrogen-bonding macromolecules, the gel can have good adhesion to a variety of materials such as glass, resin, and skin.

[0030] Furthermore, the gel has electrical conductivity, and the electrical conductivity is between 0.32-0.85 mS / cm.

[0031] Further, the performance of the gel and the corresponding test method are as follows: The test method for the tensile strength, elongation at break and toughness of the gel is as follows: the gel is prepared into a dumbbell-shaped standard sample with a width of 10 mm in the middle and a thickness of 1 mm. The sample is tested by a universal mechanical testing instrument with a tensile rate of 10 mm / min. The toughness is the area under the stress-strain curve in MJ / m 3 .

[0032] The test method of the elastic modulus of the gel is: the gel is tested by a rotational rheometer, and the storage modulus measured in the linear viscoelastic region is taken.

[0033] The skin adhesion test method is as follows: 80 mm × 15 mm × 1.5 mm gel is adhered to the pig skin surface and peeled off using a universal mechanical tester at a rate of 10 mm / min. The skin adhesion strength is calculated using the formula G = F / W, where F is the average force in the steady-state zone of the peeling process and W is the width of the hydrogel sheet being tested.

[0034] Gel mechanical strength training: The gel is stretched at a rate of 10 mm / min. After being stretched to 300% deformation, it is relaxed at the same speed and then stretched N times. The ratio of the last strength to the first stretching strength is tested.

[0035] The conductivity test method of the gel is as follows: the gel sample is cut into blocks of 1 cm×1 cm×1 mm and tested at room temperature using an electrochemical workstation.

[0036] Antibacterial property of gel: Staphylococcus aureus was used to test 10 4 CFU / mL concentration of Staphylococcus aureus was cultured on the surface of the prepared gel, and the changes in the area of ​​Escherichia coli colonies were observed after 1 week. The antibacterial activity was defined as the reduction ratio of the colony area compared with the original area, which could be clarified by Image J software.

[0037] Average survival days of exosomes: The gel was sliced, freeze-dried and then observed electronically within N days, and the number of days when more than 50% of the exosomes were spherical or quasi-spherical with intact structural morphology within the 1μm field of view.

[0038] Exosome release concentration: The gel was immersed in neutral PBS buffer and the concentration of exosome particles in the solution was measured by dynamic light scattering. During the immersion, the water was changed once a day, and the release concentration values ​​were tested on the 1st, 3rd, and 5th days. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 The original state and stretched state photos of the gel prepared in Example 1; Figure 2 This is the multiple stretching curve of the gel prepared in Example 1. DETAILED DESCRIPTION

[0040] The embodiments of the present application will be described in detail below in conjunction with examples, but those skilled in the art will understand that the following examples are only used to illustrate the present application and should not be construed as limiting the scope of the present application. Example 1

[0041] A trainable and strengthening skin chitosan-based gel dressing, which is composed of polypeptide-modified chitosan macromolecules, hydrogen-bonding macromolecules, and zwitterionic macromolecules, and the mass fraction of each component is: Peptide modified chitosan macromolecule: 6.5 Cationic modified chitosan: 24.5 Hydrogen bondable macromolecules: 6 Zwitterionic macromolecules: 15 Aldehyde crosslinker: 0.3 The polypeptide for modifying chitosan is a five-membered cyclic peptide, which is composed of arginine, glycine, aspartic acid, D-phenylalanine, and lysine, and the first and last amide bonds form a ring, and its molecular structure is as follows:

[0042] The mass of the cyclopeptide modified chitosan is 32% of the mass of chitosan.

[0043] Cyclic peptide modified chitosan-based macromolecules are commercially available products.

[0044] The ionic modified chitosan is hydroxypropyltrimethylammonium chloride chitosan, which is a commercially available product.

[0045] The hydrogen-bonding macromolecule is poly-N,N'-dimethylacrylamide, which has a molecular weight of 26,000 and is a commercially available product.

[0046] The zwitterionic macromolecule is poly([2-(methacryloyloxy)ethyl]dimethyl-(3-sulfonic acid propyl)ammonium hydroxide), with a molecular weight of 36,000, and is a commercially available product.

[0047] The aldehyde cross-linking agent is glutaraldehyde.

[0048] The preparation process of the gel is: I: Dissolve hydroxypropyltrimethylammonium chloride chitosan in an acetic acid aqueous solution with a pH value of 5.2 to a mass concentration of 5%; stir evenly and add the polypeptide-modified chitosan macromolecules; continue to stir evenly to form a prepolymer solution A; II: dissolving poly-N,N'-dimethylacrylamide, poly([2-(methacryloyloxy)ethyl]dimethyl-(3-sulfonic acid propyl)ammonium hydroxide) and glutaraldehyde in deionized water, and stirring evenly to obtain prepolymer solution B, wherein the total mass concentration of all substances is 16%; III: Add prepolymer solution B to prepolymer solution A, stir evenly, then add a small amount of NaOH aqueous solution to adjust the pH value of the solution to 9.8; IV: Heat the mixed solution to 42 o C, keep for 6 hours to obtain gel; V: The gel is repeatedly soaked and washed with pure water, and the pH value is adjusted to 7.5 to obtain the final product.

[0049] Adipose-derived stem cell exosomes are added to the gel in preparation process II, and the concentration of the exosomes in the prepolymer solution reaches 32 mg / g. The exosomes are commercially available products.

[0050] The gel was tested in the following manner: The test method for the tensile strength, elongation at break and toughness of the gel is as follows: the gel is prepared into a dumbbell-shaped standard sample with a width of 10 mm in the middle and a thickness of 1 mm. The sample is tested by a universal mechanical testing instrument with a tensile rate of 10 mm / min. The toughness is the area under the stress-strain curve in MJ / m 3 .

[0051] The test method of the elastic modulus of the gel is: the gel is tested by a rotational rheometer, and the storage modulus measured in the linear viscoelastic region is taken.

[0052] The skin adhesion test method is as follows: 80 mm × 15 mm × 1.5 mm gel is adhered to the pig skin surface and peeled off using a universal mechanical tester at a rate of 10 mm / min. The skin adhesion strength is calculated using the formula G = F / W, where F is the average force in the steady-state zone of the peeling process and W is the width of the hydrogel sheet being tested.

[0053] Gel mechanical strength training: The gel is stretched at a rate of 10 mm / min. After being stretched to 300% deformation, it is relaxed at the same speed and then stretched N times. The ratio of the last strength to the first stretching strength is tested.

[0054] The conductivity test method of the gel is as follows: the gel sample is cut into blocks of 1 cm×1 cm×1 mm and tested at room temperature using an electrochemical workstation.

[0055] Antibacterial property of gel: Staphylococcus aureus was used to test 10 4 CFU / mL concentration of Staphylococcus aureus was cultured on the surface of the prepared gel, and the changes in the area of ​​Escherichia coli colonies were observed after 1 week. The antibacterial activity was defined as the reduction ratio of the colony area compared with the original area, which could be clarified by Image J software.

[0056] Average survival days of exosomes: The gel was sliced, freeze-dried and then observed electronically within N days, and the number of days when more than 50% of the exosomes were spherical or quasi-spherical with intact structural morphology within the 1μm field of view.

[0057] Exosome release concentration: The gel was immersed in neutral PBS buffer and the concentration of exosome particles in the solution was measured by dynamic light scattering. During the immersion, the water was changed once a day, and the release concentration values ​​were tested on the 1st, 3rd, and 5th days.

[0058] Depend on Figure 1 It can be seen that the gel has excellent stretchability; Figure 2 It can be seen that the gel has stretching training properties, and its strength increases significantly after multiple stretching.

[0059] The properties of the prepared gels are shown in Table 1.

[0060] Example 2 A trainable and strengthening skin chitosan-based gel dressing, which is composed of polypeptide-modified chitosan macromolecules, hydrogen-bonding macromolecules, and zwitterionic macromolecules, and the mass fraction of each component is: Peptide modified chitosan macromolecule: 5.2 Cationic modified chitosan: 32.6 Hydrogen bondable macromolecules: 8.5 Zwitterionic macromolecules: 22.5 Aldehyde crosslinker: 0.35 The polypeptide is a cyclic peptide, a five-membered cyclic peptide, composed of arginine, glycine, aspartic acid, D-phenylalanine, and lysine, and the first and last amide bonds form a ring, and its molecular structure is as follows:

[0061] The mass of the cyclopeptide modified chitosan is 46% of the mass of chitosan.

[0062] The cyclic peptide-modified chitosan-based macromolecule is prepared according to the method described in the summary of the invention.

[0063] The cationic modified chitosan is hydroxypropyltrimethylammonium chloride chitosan, which is a commercially available product.

[0064] The hydrogen-bonding macromolecule is polyacrylamide, which has a molecular weight of 18,000 and is a commercially available product.

[0065] The zwitterionic macromolecule is polymethyl acrylate cysteine, which has a molecular weight of 39,000 and is a commercially available product.

[0066] The aldehyde cross-linking agent is a 4-arm polyethylene glycol aldehyde group with a molecular weight of 4000.

[0067] The preparation process of the gel is: I: Dissolve hydroxypropyltrimethylammonium chloride chitosan in a hydrochloric acid aqueous solution with a pH value of 5.5 to a mass concentration of 6.5%; stir evenly and add the polypeptide-modified chitosan macromolecules; continue to stir evenly to form a prepolymer solution A; II: dissolving polyacrylamide, polymethyl acrylate cysteine, and 4-arm polyethylene glycol aldehyde in deionized water, stirring evenly to obtain prepolymer solution B, wherein the total mass concentration of all substances is 12%; III: Add prepolymer solution B to prepolymer solution A, stir evenly, then add a small amount of NaOH aqueous solution to adjust the pH value of the solution to 10.1; IV: Heat the mixed solution to 40 o C, keep for 7 hours to obtain gel; V: The gel is repeatedly soaked and washed with pure water, and the pH value is adjusted to 7.2 to obtain the final product.

[0068] The gel is added with umbilical cord mesenchymal stem cell exosomes in preparation process II, and the concentration of the exosomes in the prepolymer solution reaches 26.8 mg / g.

[0069] The properties of the prepared gels are shown in Table 1.

[0070] Example 3 A trainable and strengthening skin chitosan-based gel dressing, which is composed of polypeptide-modified chitosan macromolecules, hydrogen-bonding macromolecules, and zwitterionic macromolecules, and the mass fraction of each component is: Peptide modified chitosan macromolecule: 4.4 Cationic modified chitosan: 34.2 Hydrogen bondable macromolecules: 10.5 Zwitterionic macromolecules: 14.5 Aldehyde crosslinker: 0.15 The polypeptide is cyclopeptide-polyethylene glycol-folic acid, which is a commercially available product. It is modified and connected to chitosan segments using the method disclosed in patent 201810539270.8, and its mass is 24% of the mass of the modified chitosan.

[0071] The cationic modified chitosan is hydroxypropyltrimethylammonium chloride chitosan, which is a commercially available product.

[0072] The hydrogen-bondable macromolecule is a polyethylene glycol-polyvinyl alcohol graft copolymer, which has a molecular weight of 22,000 and a mass of polyvinyl alcohol of 52% of that of polyethylene glycol. It is a commercially available product.

[0073] The zwitterionic macromolecule is polymethacrylate carboxybetaine, which has a molecular weight of 45,000 and is a commercially available product.

[0074] The aldehyde cross-linking agent is glutaraldehyde.

[0075] The preparation process of the gel is: I: Dissolve hydroxypropyltrimethylammonium chloride chitosan in a hydrochloric acid aqueous solution with a pH value of 5.5 to a mass concentration of 7.2%; stir evenly and add the polypeptide-modified chitosan macromolecules; continue to stir evenly to form a prepolymer solution A; II: dissolving polyethylene glycol-polyvinyl alcohol graft copolymer, polymethacrylate carboxybetaine and glutaraldehyde in deionized water, stirring evenly to obtain prepolymer solution B, wherein the total mass concentration of all substances is 18%; III: Add prepolymer solution B to prepolymer solution A, stir evenly, then add a small amount of NaOH aqueous solution to adjust the pH value of the solution to 10.4; IV: Heat the mixed solution to 38 o C, keep for 6 hours to obtain gel; V: The gel is repeatedly soaked and washed with pure water, and the pH value is adjusted to 7.5 to obtain the final product.

[0076] The gel is added with adipose-derived mesenchymal stem cell exosomes in preparation process II, and the concentration of the exosomes in the prepolymer solution reaches 35.6 mg / g.

[0077] The properties of the prepared gels are shown in Table 1.

[0078] Example 4 A trainable and strengthening skin chitosan-based gel dressing, which is composed of polypeptide-modified chitosan macromolecules, hydrogen-bonding macromolecules, and zwitterionic macromolecules, and the mass fraction of each component is: Peptide modified chitosan macromolecule: 7.8 Cationic modified chitosan: 22.6 Hydrogen bondable macromolecules: 8.4 Zwitterionic macromolecules: 26.5 Aldehyde crosslinker: 0.4 The polypeptide is a cyclic peptide, a five-membered cyclic peptide, composed of arginine, glycine, aspartic acid, D-phenylalanine, and lysine, and the first and last amide bonds form a ring, and its molecular structure is as follows:

[0079] Its mass is 32% of the mass of the modified chitosan.

[0080] Cyclic peptide modified chitosan-based macromolecules are commercially available products.

[0081] The cationic modified chitosan is hydroxypropyltrimethylammonium chloride chitosan, which is a commercially available product.

[0082] The hydrogen-bonding macromolecule is poly-N,N'-dimethylacrylamide, which has a molecular weight of 18,000 and is a commercially available product.

[0083] The zwitterionic macromolecule is polymethyl acrylate serine, which has a molecular weight of 52,000 and is a commercially available product.

[0084] The aldehyde cross-linking agent is glutaraldehyde.

[0085] The preparation process of the gel is: I: Dissolve hydroxypropyltrimethylammonium chloride chitosan in an acetic acid aqueous solution with a pH value of 6.2 to a mass concentration of 7.8%; add polypeptide-modified chitosan macromolecules after stirring evenly, and continue stirring evenly to form prepolymer solution A; II: dissolving poly N, N'-dimethylacrylamide, polymethyl acrylate serine and glutaraldehyde in deionized water, stirring evenly to obtain a prepolymer solution, wherein the mass concentration of all substances is 15%; III: Add prepolymer solution B to prepolymer solution A, stir evenly, then add a small amount of NaOH aqueous solution to adjust the pH value of the solution to 10.0; IV: Heat the mixed solution to 42 o C, keep for 7 hours to obtain gel; V: The gel is repeatedly soaked and washed with pure water, and the pH value is adjusted to 7.5 to obtain the final product.

[0086] The gel is added with adipose-derived stem cell exosomes in preparation process II, and the concentration of the exosomes in the prepolymer solution reaches 42.7 mg / g.

[0087] The properties of the prepared gels are shown in Table 1.

[0088] Comparative Example 1 A chitosan-based gel dressing for training and strengthening the skin, all preparation processes are consistent with those of Example 1, except that the polypeptide-modified chitosan macromolecules are not added, and the mass thereof is supplemented into the cationic-modified chitosan, that is, the added substances are in the following proportions: Cationic modified chitosan: 31.0 Hydrogen bondable macromolecules: 6 Zwitterionic macromolecules: 15 Aldehyde crosslinker: 0.3 The properties of the prepared gels are shown in Table 2; It can be seen from the performance that without the addition of polypeptide-modified chitosan macromolecules, the mechanical properties of the gel did not show a significant decrease, but the skin adhesion decreased significantly, and the viability and sustained-release of the exosomes decreased significantly, which was not conducive to the loading and release of the exosomes.

[0089] Comparative Example 2 A chitosan-based gel dressing for training and strengthening the skin, all preparation processes are consistent with those of Example 1, except that the zwitterionic macromolecules are not added, and their mass is supplemented into the hydrogen-bonding macromolecules, that is, the added substances are in the following proportions: Peptide modified chitosan macromolecule: 6.5 Cationic modified chitosan: 24.5 Hydrogen-bondable macromolecules: 21 Aldehyde crosslinker: 0.3 The properties of the prepared gels are shown in Table 2; It can be seen from the performance that due to the lack of the addition of zwitterionic macromolecules and the increase in the amount of hydrogen-bonding macromolecules, the strength and elastic modulus of the gel increased significantly, but the adhesion decreased significantly, and it was not conducive to the survival and sustained release of exosomes.

[0090] Comparative Example 3 A chitosan-based gel dressing for training and strengthening the skin, all preparation processes are consistent with those of Example 1, except that the cationic modified chitosan is not added, and its mass is supplemented into the zwitterionic macromolecule, that is, the added substances are in the following proportions: Peptide modified chitosan macromolecule: 6.5 Hydrogen bondable macromolecules: 6 Zwitterionic macromolecules: 39.5 Aldehyde crosslinker: 0.3 The properties of the prepared gels are shown in Table 2; It can be seen from the performance that due to the lack of addition of cationic modified chitosan and the increase in the amount of zwitterionic macromolecules, the strength and elastic modulus of the gel are slightly reduced, the conductivity is improved, the antibacterial effect is almost eliminated, the strength training effect still exists, the viability of exosomes is reduced, and the burst release is obvious.

[0091] Comparative Example 4 A chitosan-based gel dressing for training and strengthening the skin, all preparation processes are consistent with those of Example 1, except that hydrogen-bonding macromolecules are not added, and their mass is supplemented into zwitterionic macromolecules, that is, the added substances are in the following proportions: Peptide modified chitosan macromolecule: 6.5 Cationic modified chitosan: 24.5 Zwitterionic macromolecules: 21 Aldehyde crosslinker: 0.3 The properties of the prepared gels are shown in Table 2; It can be seen from the performance that due to the lack of hydrogen-bonding macromolecules and the increase in the amount of zwitterionic macromolecules, the strength and elastic modulus of the gel are greatly reduced, the conductivity is improved, the adhesion is slightly reduced, the intensity training property disappears, and the viability and sustained release of the exosomes are almost unaffected. This shows that hydrogen-bonding macromolecules also play an important role in providing training properties.

[0092] Table 1, Performance summary of the gel prepared in the examples: Example 1 Example 2 Example 3 Example 4 Tensile strength (MPa) 1.23 1.46 1.65 1.17 <![CDATA[Toughness (MJ / m 3 )]]> 5.2 6.1 4.9 4.4 Elongation at break (%) 526.9 491.4 439.4 619.3 Elastic modulus (KPa) 12.6 17.5 21.4 9.2 <![CDATA[Skin adhesion toughness (J / m 2 )]]> 142.6 170.4 155.6 184.3 Training (%) 5th: 11810th: 13120th: 161 5th: 10810th: 11920th: 136 5 times: 10910 times: 11620 times: 144 5th: 11410th: 12620th: 149 Conductivity (mS / cm) 0.31 0.42 0.39 0.38 Antibacterial activity (%) 84.2 89.4 94.5 85.6 Average survival days of exosomes 4 6 5 6 Exosome release concentration (mg / g) 1 day: 12.43 days: 6.25 days: 3.7 1 day: 9.23 days: 4.35 days: 3.6 1 day: 11.93 days: 7.45 days: 5.1 1 day: 16.33 days: 8.25 days: 5.7 Table 2: Summary of properties of gels prepared in comparative examples: Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 Tensile strength (MPa) 1.31 2.12 1.14 0.74 <![CDATA[Toughness (MJ / m 3 )]]> 5.6 6.7 5.4 4.2 Elongation at break (%) 541.7 691.4 535.7 531.6 Elastic modulus (KPa) 13.1 27.5 10.3 7.1 <![CDATA[Skin adhesion toughness (J / m 2 )]]> 43.1 40.4 105.8 148.4 Training (%) 5th: 11410th: 12720th: 142 5 times: 8410 times: 7820 times: 69 5th: 10510th: 11220th: 127 5 times: 7210 times: 5420 times: 43 Conductivity (mS / cm) 0.36 0.04 0.39 0.44 Antimicrobial 86.7 96.4 14.6 87.5 Average survival days of exosomes 2 3 1 4 Exosome release concentration (mg / g) 1 day: 22.33 days: 3.15 days: 0.4 1 day: 16.93 days: 4.75 days: 0.6 1 day: 18.93 days: 3.75 days: 0.2 1 day: 11.93 days: 6.45 days: 4.1

Claims

1. A chitosan-based gel dressing for training and strengthening the skin, which is composed of polypeptide-modified chitosan macromolecules, cation-modified chitosan, hydrogen-bonding macromolecules, and zwitterionic macromolecules, and the mass fraction of each component is: Peptide modified chitosan macromolecule: 4-8 Cationic modified chitosan: 15-40 Hydrogen bondable macromolecules: 5-12 Zwitterionic macromolecules: 10-30 Aldehyde crosslinking agent: 0.1-0.5 Its characteristics are also: The polypeptide is a cyclic peptide or a water-soluble cyclic peptide derivative, and its content in the polypeptide-modified chitosan macromolecule is between 10% and 40% of the mass of the chitosan.

2. The trainable skin-strengthening chitosan-based gel dressing according to claim 1, characterized in that: The cyclic peptide is a five-membered cyclic peptide, which is composed of arginine, glycine, aspartic acid, D-phenylalanine, and lysine, and the first and last amide bonds form a ring, and its molecular structure is as follows:

3. The trainable skin-strengthening chitosan-based gel dressing according to claim 1, characterized in that: The cationic modified chitosan is quaternary ammonium salt modified chitosan, and the degree of modification is between 15% and 30% calculated based on the mass of chitosan.

4. The trainable skin-strengthening chitosan-based gel dressing according to claim 1, characterized in that: The hydrogen-bonding macromolecule is a hydrophilic macromolecule with hydrogen-bonding groups such as amine and hydroxyl groups, including polyacrylamide and its hydrophilic derivatives, poly(N-hydroxyethyl acrylamide), and polyethylene glycol-polyvinyl alcohol graft copolymer.

5. The trainable skin-strengthening chitosan-based gel dressing according to claim 1, characterized in that: The zwitterionic macromolecule is one of polymethacrylate sulfobetaine, polymethacryloylethyl sulfobetaine, polymethacrylate carboxybetaine, polymethyl acrylate cysteine ​​and polymethyl acrylate serine, and has a molecular weight between 30,000 and 60,000.

6. The trainable skin-strengthening chitosan-based gel dressing according to claim 1, characterized in that: The aldehyde-based crosslinking agent can be a small molecule aldehyde-based crosslinking agent or a macromolecular aldehyde-based crosslinking agent; the small molecule aldehyde-based crosslinking agent is glutaraldehyde, and the macromolecular aldehyde-based crosslinking agent is terminal aldehyde multi-arm polyethylene glycol, and the molecular weight is between 2000-6000.

7. The trainable skin-strengthening chitosan-based gel dressing according to claim 1, characterized in that: The preparation process of the gel is: I: dissolving the cationic modified chitosan in a weak acid aqueous solution with a pH value between 5 and 6.5, with a mass concentration between 3 and 8%; adding the polypeptide modified chitosan macromolecule after stirring evenly, and continuing to stir evenly to form a prepolymer solution A; II: dissolving the hydrogen-bonding macromolecule, the zwitterionic macromolecule, and the aldehyde-based crosslinking agent in deionized water, and stirring them evenly to obtain a prepolymer solution B, wherein the mass concentration of the solute is between 10-20%; III: Add prepolymer solution B to prepolymer solution A, stir evenly, then add a small amount of NaOH aqueous solution to adjust the pH value of the solution to between 9-10.5; IV: Heat the mixed solution to 35-45 o C, keep for 4-8 hours to obtain gel; V: The gel is repeatedly soaked and washed with pure water, and the pH value is adjusted to between 7 and 8 to obtain the final product.

8. The trainable skin-strengthening chitosan-based gel dressing according to claim 1, characterized in that: The gel can effectively load drugs such as stem cells and stem cell exosomes and achieve sustained release. The drug loading process can add the required loaded drugs in process II.

9. The trainable skin-strengthening chitosan-based gel dressing according to claim 1, characterized in that: The gel has tensile training strengthening properties and can achieve improvements in strength and modulus through repeated stretching-relaxation within the tensile fracture deformation range, with the improvement limit being between 50% and 100% of the initial tensile strength.

Citation Information

Patent Citations

  • Biological macromolecule based on modified chitosan as well as preparation method and application thereof

    CN109053928A

  • c(RGDfk) cyclic peptide-chitosan stearic acid graft drug-loaded micelles as well as preparation and application thereof

    CN109851799A

Cited By

  • Biodegradable high-toughness high-barrier composite film

    CN120206933A